Bill > HJR162

This joint resolution encourages the Alabama Medicaid Agency to investigate the financial implications of covering GLP-1 medications, which are drugs used for weight management. The resolution highlights that obesity is a significant health issue with substantial economic costs, impacting both national and state economies, and that a considerable number of Alabama residents may be eligible for these medications. Therefore, the agency is urged to assess potential cost savings, evaluate the overall expenses of GLP-1 coverage in light of new drug pricing models, engage with healthcare providers and stakeholders to improve health outcomes and reduce costs, and then report its findings to the Alabama Legislature before the 2027 legislative session.